Skip to Main Content

Paper Details

The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.
NPJ Parkinsons Dis
7
2021
Parkinson's, Participants, TOPAZ, Zoledronic acid, movement disorders, neurodegenerative parkinsonism, osteoporosis, parkinsonism, participants, people, zoledronic acid
Author NameAffiliation
Caroline M TannerWeill Institute for Neurosciences, University of California San Francisco
Caroline M TannerParkinson's Disease Research Education and Clinical Center
Michael A SchwarzschildMassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital
Samuel M GoldmanWeill Institute for Neurosciences, University of California San Francisco
Samuel M GoldmanUniversity of California San Francisco
David G StandaertUniversity of Alabama at Birmingham
Douglas C BauerUniversity of California San Francisco
  • 1 - 7

Datasets

Release 1.2